A bird flu vaccine from Moderna is in early stages of development

The U.S. government is giving drugmaker Moderna $176 million to develop an mRNA vaccine against the bird flu amid the ongoing outbreak in dairy cows across the country. The vaccine is in the early stages of development and would not be available until at least next year, Dawn O’Connell, assistant secretary for preparedness and response at the Department of Health and Human Services, said during a call with reporters Tuesday. “The timeline may change, but we anticipate starting phase three trials in 2025,” O’Connell said. While the vaccine would target...